Medco Health Solution News

Economic worries could spur investors to seek out blue-chip stocks this quarter.

CVS Caremark Corp. said Thursday its third-quarter profit jumped 39 percent to more than $1 billion on a boost from pharmacy benefits services and drugstore sales.

Factory orders rebound in September aided by gains in autos, machinery and military aircraft.

Nov. 3 -- David Snow, chief executive officer of Medco Health Solutions Inc., talks with Bloomberg's Matt Miller and Carol Massar about the company's acquisition strategy.

Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, is scheduled to report its third-quarter results Tuesday morning.

MasterCard and Kraft Foods will be among a handful of companies reporting earnings before and after Tuesday's trading session.

These companies are projected to increase revenue and profit by at least 12% in the coming year and have "buy" ratings from our quantitative model, which considers more than 60 factors.

Accredo Health Group Inc. announced a 10-year renewal of its 240,000-square-foot headquarters at Century Center, positioning the nation's largest specialty pharmacy and a major fixture of Memphis' health care industry for future growth.

FRANKLIN LAKES, N.J., Oct. 26 /PRNewswire-FirstCall/ -- Executives for Medco Health Solutions, Inc.

Sanofi-Aventis is paying privately-held Wellstat Therapeutics Corp. up to $350 million under terms of a licensing deal for a potential diabetes drug, the companies said Wednesday.

Medco Health Solutions, Inc. and the American Medical Association today announced the findings of a national benchmark survey on physicians' acceptance, use and education regarding pharmacogenomic testing.

Accredo Health Group Inc. has signed a 10-year renewal for its 240,000-square-foot headquarters at Century Center office park.

Medco Health Solutions, Inc. announced it will conduct a head-to-head study of Plavix and Effient that measures how the effectiveness of these drugs in heart patients is impacted by their genetic make-up. The study will examine whether the 70 to 75 percent of patients who are "extensive metabolizers" of clopidogrel - because they were born with a ...

NEW YORK - Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with the newer Effient to study.

Executives in accounting, advertising, finance, high tech & new media, law and real estate have all found new digs.

The following companies are projected to increase revenue and profit by at least 12% in the coming year and receive "buy"-ratings from our quantitative model, which considers more than 60 factors.

The following companies have market values of more than $10 billion and receive "buy" ratings from our proprietary quantitative model, which considers more than 60 factors.

The CEO of Medco Health Services, one of the largest managers of insurers' prescription programs, talks about the main way Americans interact with their health care.

All data is gathered from primary source. Reports are available in easily accessible PDF format and data is consistently presented.

Panel Discussions Also to Feature Top Experts on the Battle Against H1N1 WASHINGTON, Oct.